US Stock MarketDetailed Quotes

OCUP Ocuphire Pharma

Watchlist

1.640
-0.080-4.65%

Close Aug 7 16:00 ET

1.680
+0.040+2.44%

Post 20:02 ET

42.52MMarket Cap-3489P/E (TTM)

Ocuphire Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-2.17%1.71M

-52.20%19.05M

-95.76%1.69M

11.94M

3.67M

1.75M

6,665.70%39.85M

39.85M

Operating revenue

-2.17%1.71M

-52.20%19.05M

-95.76%1.69M

--11.94M

--3.67M

--1.75M

6,665.70%39.85M

--39.85M

--0

Cost of revenue

Gross profit

Operating expense

19.53%9.42M

36.94%29.61M

26.24%7.12M

22.28%5.55M

83.54%9.06M

21.08%7.88M

-7.17%21.62M

-8.29%5.64M

-3.88%4.54M

-31.77%4.94M

Selling and administrative expenses

104.38%4.67M

64.52%11.96M

59.64%3.28M

20.67%2.06M

144.37%4.34M

31.62%2.29M

-10.49%7.27M

45.26%2.05M

6.77%1.7M

-47.89%1.78M

-General and administrative expense

----

64.52%11.96M

----

--7.27M

----

Research and development costs

-15.12%4.75M

22.97%17.65M

7.11%3.84M

23.25%3.49M

49.37%4.72M

17.25%5.6M

-5.39%14.36M

-24.28%3.59M

-9.31%2.84M

-17.42%3.16M

Operating profit

-25.72%-7.71M

-157.96%-10.56M

-115.87%-5.43M

240.72%6.39M

-9.13%-5.39M

5.79%-6.13M

180.27%18.23M

656.26%34.21M

-7.23%-4.54M

30.81%-4.94M

Net non-operating interest income expense

63.49%600K

-14,655.56%-1.33M

-1.33M

7,440.00%367K

-350.00%-9K

-4K

Non-operating interest income

63.49%600K

----

--367K

----

Non-operating interest expense

----

--0

----

350.00%9K

--0

--4K

Total other finance cost

----

--1.33M

--0

--1.33M

----

Other net income (expense)

107.41%2K

13,792.86%1.92M

1,273.91%632K

7,285.71%517K

2,753.33%428K

67.07%-27K

99.96%-14K

128.57%46K

250.00%7K

1,400.00%15K

Gain on sale of security

----

--80K

--19K

--61K

----

---27K

----

Other non- operating income (expenses)

--2K

13,221.43%1.84M

1,232.61%613K

6,414.29%456K

2,753.33%428K

----

91.08%-14K

128.57%46K

250.00%7K

1,400.00%15K

Income before tax

-22.71%-7.11M

-154.79%-9.97M

-114.00%-4.8M

223.04%5.58M

-0.69%-4.96M

12.19%-5.79M

132.11%18.2M

642.63%34.26M

-7.12%-4.53M

30.96%-4.93M

Income tax

-96.19%12K

-100.63%-2K

14K

315K

Net income

-22.71%-7.11M

-155.83%-9.99M

-114.13%-4.8M

222.73%5.56M

-0.69%-4.96M

12.19%-5.79M

131.55%17.89M

637.64%33.94M

-7.12%-4.53M

30.96%-4.93M

Net income continuous Operations

-22.71%-7.11M

-155.83%-9.99M

-114.13%-4.8M

222.73%5.56M

-0.69%-4.96M

12.19%-5.79M

131.55%17.89M

637.64%33.94M

-7.12%-4.53M

30.96%-4.93M

Minority interest income

Net income attributable to the parent company

-22.71%-7.11M

-155.83%-9.99M

-114.13%-4.8M

222.73%5.56M

-0.69%-4.96M

12.19%-5.79M

131.55%17.89M

637.64%33.94M

-7.12%-4.53M

30.96%-4.93M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-22.71%-7.11M

-155.83%-9.99M

-114.13%-4.8M

222.73%5.56M

-0.69%-4.96M

12.19%-5.79M

131.55%17.89M

637.64%33.94M

-7.12%-4.53M

30.96%-4.93M

Basic earnings per share

-3.57%-0.29

-151.11%-0.46

-112.88%-0.21

218.18%0.26

4.00%-0.24

20.00%-0.28

123.56%0.9

565.71%1.63

12.00%-0.22

51.92%-0.25

Diluted earnings per share

-3.57%-0.29

-152.87%-0.46

-113.29%-0.21

213.64%0.25

4.00%-0.24

20.00%-0.28

122.77%0.87

551.43%1.58

12.00%-0.22

51.92%-0.25

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-2.17%1.71M	-52.20%19.05M	-95.76%1.69M	11.94M	3.67M	1.75M	6,665.70%39.85M	39.85M	0	0
Operating revenue	-2.17%1.71M	-52.20%19.05M	-95.76%1.69M	--11.94M	--3.67M	--1.75M	6,665.70%39.85M	--39.85M	--0	--0
Cost of revenue
Gross profit
Operating expense	19.53%9.42M	36.94%29.61M	26.24%7.12M	22.28%5.55M	83.54%9.06M	21.08%7.88M	-7.17%21.62M	-8.29%5.64M	-3.88%4.54M	-31.77%4.94M
Selling and administrative expenses	104.38%4.67M	64.52%11.96M	59.64%3.28M	20.67%2.06M	144.37%4.34M	31.62%2.29M	-10.49%7.27M	45.26%2.05M	6.77%1.7M	-47.89%1.78M
-General and administrative expense	----	64.52%11.96M	----	----	----	----	--7.27M	----	----	----
Research and development costs	-15.12%4.75M	22.97%17.65M	7.11%3.84M	23.25%3.49M	49.37%4.72M	17.25%5.6M	-5.39%14.36M	-24.28%3.59M	-9.31%2.84M	-17.42%3.16M
Operating profit	-25.72%-7.71M	-157.96%-10.56M	-115.87%-5.43M	240.72%6.39M	-9.13%-5.39M	5.79%-6.13M	180.27%18.23M	656.26%34.21M	-7.23%-4.54M	30.81%-4.94M
Net non-operating interest income expense	63.49%600K	-14,655.56%-1.33M	0	-1.33M	0	7,440.00%367K	-350.00%-9K	0	0	-4K
Non-operating interest income	63.49%600K	----	----	----	----	--367K	----	----	----	----
Non-operating interest expense	----	--0	--0	--0	--0	----	350.00%9K	--0	--0	--4K
Total other finance cost	----	--1.33M	--0	--1.33M	----	----	----	----	----	----
Other net income (expense)	107.41%2K	13,792.86%1.92M	1,273.91%632K	7,285.71%517K	2,753.33%428K	67.07%-27K	99.96%-14K	128.57%46K	250.00%7K	1,400.00%15K
Gain on sale of security	----	--80K	--19K	--61K	----	---27K	----	----	----	----
Other non- operating income (expenses)	--2K	13,221.43%1.84M	1,232.61%613K	6,414.29%456K	2,753.33%428K	----	91.08%-14K	128.57%46K	250.00%7K	1,400.00%15K
Income before tax	-22.71%-7.11M	-154.79%-9.97M	-114.00%-4.8M	223.04%5.58M	-0.69%-4.96M	12.19%-5.79M	132.11%18.2M	642.63%34.26M	-7.12%-4.53M	30.96%-4.93M
Income tax	0	-96.19%12K	-100.63%-2K	14K	0	0	315K	315K	0	0
Net income	-22.71%-7.11M	-155.83%-9.99M	-114.13%-4.8M	222.73%5.56M	-0.69%-4.96M	12.19%-5.79M	131.55%17.89M	637.64%33.94M	-7.12%-4.53M	30.96%-4.93M
Net income continuous Operations	-22.71%-7.11M	-155.83%-9.99M	-114.13%-4.8M	222.73%5.56M	-0.69%-4.96M	12.19%-5.79M	131.55%17.89M	637.64%33.94M	-7.12%-4.53M	30.96%-4.93M
Minority interest income
Net income attributable to the parent company	-22.71%-7.11M	-155.83%-9.99M	-114.13%-4.8M	222.73%5.56M	-0.69%-4.96M	12.19%-5.79M	131.55%17.89M	637.64%33.94M	-7.12%-4.53M	30.96%-4.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-22.71%-7.11M	-155.83%-9.99M	-114.13%-4.8M	222.73%5.56M	-0.69%-4.96M	12.19%-5.79M	131.55%17.89M	637.64%33.94M	-7.12%-4.53M	30.96%-4.93M
Basic earnings per share	-3.57%-0.29	-151.11%-0.46	-112.88%-0.21	218.18%0.26	4.00%-0.24	20.00%-0.28	123.56%0.9	565.71%1.63	12.00%-0.22	51.92%-0.25
Diluted earnings per share	-3.57%-0.29	-152.87%-0.46	-113.29%-0.21	213.64%0.25	4.00%-0.24	20.00%-0.28	122.77%0.87	551.43%1.58	12.00%-0.22	51.92%-0.25
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall